Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

A-share midday review | The "tug-of-war" between the US and Iran sparks a massive fluctuation in A-share "electrocardiogram"! The index sees a significant differentiation, with green energy and military industries sectors strengthening.

JP Morgan: Lowers AIA (01299) target price to 112 Hong Kong dollars, maintains "overweight" rating.

JP Morgan: Upgrade LI NING (02331) rating to "buy" with a target price raised to 25.6 Hong Kong dollars.
A-share midday review | The "tug-of-war" between the US and Iran sparks a massive fluctuation in A-share "electrocardiogram"! The index sees a significant differentiation, with green energy and military industries sectors strengthening.

JP Morgan: Lowers AIA (01299) target price to 112 Hong Kong dollars, maintains "overweight" rating.

JP Morgan: Upgrade LI NING (02331) rating to "buy" with a target price raised to 25.6 Hong Kong dollars.






